Keck School Faculty

Howard Silberman, MD
Howard Silberman, MD
Professor of Surgery
1510 San Pablo St. Health Sciences Campus Los Angeles
Dr. Howard Silberman, Professor of Surgery at the Keck School of Medicine of the University of Southern California, was awarded the M.D. degree by the Jefferson Medical College in Philadelphia and received his postgraduate training in surgery at the Hospital of the University of Pennsylvania. He is a Diplomate of the American Board of Surgery, a Fellow of the American College of Surgeons, and has been elected to membership in various professional organizations, including the Society of University Surgeons, the American Society of Clinical Oncology, the Society of Surgical Oncology, the American Society of Breast Surgeons, the Society for Surgery of the Alimentary Tract, and the American Society for Parenteral and Enteral Nutrition. As a member of the full-time Attending Staff of the USC/Norris Cancer Hospital, Dr. Silberman specializes in the management of breast cancer as well as tumors of the gastrointestional tract and malignant melanoma. He serves as the Associate Director of the Harold E. and Henrietta C. Lee Breast Center at the USC/Norris Comprehensive Cancer Center and Hospital. He also attends in the Division of Tumor and Endocrine Surgery at the Los Angeles County-USC Medical Center. Dr. Silberman’s clinical interests are reflected in his book, Principles and Practice of Surgical Oncology: Multidisciplinary Approach to Difficult Problems. This work considers the management of patients with complicated, advanced, or unusual tumors of the stomach, pancreas, small intestine, colon, rectum, and soft tissues including breast cancer, melanoma, and sarcoma. The text emphasizes a combined multidisciplinary approach (drug therapy, radiotherapy, and surgery) to the treatment of cancer. Dr. Silberman also has a long standing interest in surgical nutrition and is the author of text Parenteral and Enteral Nutrition.

Modified Bi-Rads Scoring of Breast Imaging Findings Improves Clinical Judgment Breast J. 2015 Nov-Dec; 21(6):642-50. . View in PubMed

Update and Review on the Surgical Management of Primary Cutaneous Melanoma Healthcare (Basel). 2014 Jun 10; 2(2):234-49. . View in PubMed

Image of the month-quiz case Arch Surg. 2012 Sep 01; 147(9). . View in PubMed

Image of the month-quiz caseDiagnosis: primary adenocarcinoma. Arch Surg. 2012 Sep; 147(9):887-8. . View in PubMed

Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast Am J Surg. 2006 Oct; 192(4):416-9. . View in PubMed

Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast Am J Surg. 2006 Oct; 192(4):420-2. . View in PubMed

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins Am J Surg. 2005 Oct; 190(4):521-5. . View in PubMed

Perioperative adjunctive treatment in the management of operable gastric cancer J Surg Oncol. 2005 Jun 01; 90(3):174-86; discussion 186-7. . View in PubMed

Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast Am J Surg. 2004 Oct; 188(4):371-6. . View in PubMed

MammoSite radiation therapy system Breast. 2003 Dec; 12(6):491-6. . View in PubMed

Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy Am J Surg. 2002 Nov; 184(5):403-9. . View in PubMed

Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer Am J Surg. 2002 Oct; 184(4):337-40. . View in PubMed

Powered by SC CTSI
Go to Top